Breast Cancer Research. Ageing as Predisposing Factor

Table of Contents

1. Introduction

2. Literature Review Related to the Topic

2.1 i. Lifetime Risks and Incidence of Breast Cancer by Age and Molecular Subtype

2.2 ii. Genetics and Breast Cancer Risks with Age

2.3 iii. Prognosis

2.4 iv. The length of menstrual cycle and the Age at menarche

2.5 v. Age at Menopause

2.6 vi. microRNAs and breast cancer

3. Methodology

3.1 Case 1: A Meta-analysis and Systematic Review of the Risk Factors for Breast Cancer for Women of between 40 and 60 Years

3.2 Case 2: A Vivid Analysis of the Progesterone Receptor Negative, Estrogen Receptor Negative, and HER2 Negative Invasive Breast Cancers or rather the Triple Negative Phenotypes

4. Results

5. Discussion

6. Limitations

7. Conclusion

8. Recommendations

Research Objectives and Topics

This research aims to explore and analyze whether aging acts as a primary predisposing factor for breast cancer among women in the United Kingdom, specifically examining how age-related variations influence diagnosis, treatment options, and patient outcomes.

• The correlation between increasing age and breast cancer incidence.
• Genetic mutations (such as BRCA1/BRCA2) and their age-dependent impact.
• The influence of hormonal factors, including menarche and menopause, on cancer risk.
• Molecular profiling and breast cancer subtypes across different age groups.
• Clinical management challenges for younger versus elderly patient populations.

Excerpt from the Book

Summary of Chapters

Introduction: Provides an overview of the global prevalence of breast cancer, highlighting the significant correlation between age and increasing mortality and incidence rates.

Literature Review Related to the Topic: Examines existing research on biological, genetic, and hormonal risk factors, including the impact of menarche, menopause, and molecular subtypes on breast cancer.

Methodology: Details the systematic review and meta-analysis approach used to evaluate risk factors, specifically focusing on women aged 40–60 and triple-negative breast cancer phenotypes.

Results: Presents findings from the data analysis, confirming that breast cancer incidence rises significantly with age and that specific biological factors vary by age bracket.

Discussion: Interprets the research findings, emphasizing the heterogeneity of breast cancer in elderly populations and the influence of modifiable factors like body mass index.

Limitations: Acknowledges the constraints of the study, including the reliance on English-language literature and the challenges of excluding certain cofounding variables.

Conclusion: Synthesizes the evidence that age is a fundamental predisposing factor and calls for improved awareness, screening, and counseling.

Recommendations: Suggests practical lifestyle changes and further research into advanced mammography techniques to improve early detection.

Keywords

Breast Cancer, Aging, Oncology, Risk Factors, Mammography, Hormone Therapy, BRCA1, BRCA2, Menopause, Menarche, Triple-Negative Phenotype, Molecular Profiling, Public Health, Mortality Rate, Cancer Screening.

Frequently Asked Questions

What is the primary focus of this research?

The work investigates the role of aging as a predisposing factor for breast cancer, analyzing how it influences the development, diagnosis, and management of the disease in women.

What are the central thematic areas covered?

The paper covers the relationship between age and incidence, the impact of genetic mutations, hormonal influences throughout a woman's life, and the clinical challenges of managing breast cancer in both younger and elderly patients.

What is the main objective of the study?

The primary objective is to explore and analyze whether aging contributes significantly to breast cancer risk in the United Kingdom, focusing on how age variations affect treatment decisions.

Which scientific methodology is employed?

The research uses a biological-based literature review and systematic analysis of existing studies, databases, and clinical registries to synthesize data on age-related breast cancer risks.

What topics are discussed in the main body?

The main body discusses molecular subtypes, genetic predisposition (BRCA genes), hormonal milestones like menarche and menopause, and clinical outcomes for different age cohorts.

Which keywords characterize this work?

Key terms include breast cancer, aging, molecular profiling, BRCA1/2 mutations, mammography screening, and hormone-related risk factors.

How does menopause impact the risk of breast cancer?

The study notes that menopause represents a period of changing hormonal production, and the timing of menopause significantly alters the risk profile, with later menopause often associated with higher risks.

Why is triple-negative breast cancer discussed separately?

Triple-negative breast cancer is analyzed as a specific, more aggressive phenotype that shows distinct prevalence patterns across different age groups, particularly in younger women.